Oclacitinib maleate is a veterinary drug used in dogs to treat itching and inflammation from allergic and atopic dermatitis. It works by inhibiting Janus kinase (JAK1) enzymes, blocking signals that cause itching and allergic reactions. It provides fast relief, often within 4 hours, and is safe for dogs over 12 months old. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include VON733L42A, Apoquel, N-methyl-1-(trans-4-(methyl(7H-pyrrolo[2 and 3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide maleate(1:x). Its PubChem CID is 44631937.
Oclacitinib maleate
| CAS No | 1208319-27-0 |
|---|---|
| Molecular Formula | C19H27N5O6S |
| Molecular Weight | 453.5 g/mol |
| Synonyms | (Z)-but-2-enedioic acid;N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Oclacitinib maleate is a veterinary drug used in dogs to treat itching and inflammation from allergic and atopic dermatitis. It works by inhibiting Janus kinase (JAK1) enzymes, blocking signals that cause itching and allergic reactions.
The listed CAS number is 1208319-27-0.
The listed molecular formula is C19H27N5O6S.
The listed molecular weight is 453.5 g/mol.
(Z)-but-2-enedioic acid;N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide.
The source lists VON733L42A, Apoquel, N-methyl-1-(trans-4-(methyl(7H-pyrrolo[2 and 3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide maleate(1:x).